Zoetis Inc. Other Comprehensive Income (Loss), Net of Tax
Zoetis Inc. (ZTS) reported Other Comprehensive Income (Loss), Net of Tax of -$24.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- Zoetis Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$24.00M, a 123.08% decline year-over-year.
- Zoetis Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $32.00M, a 63.64% decline year-over-year.
- Zoetis Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$16.00M.
- Zoetis Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $59.00M.
- Zoetis Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $106.00M.
- Zoetis Inc. other comprehensive income (loss), net of tax for fiscal 2024 was -$101.00M.
- Zoetis Inc. other comprehensive income (loss), net of tax for fiscal 2023 was -$22.00M.
- Zoetis Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$53.00M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.00M 10-Q · filed 2026-08-06 | $8.00M 10-Q · filed 2026-08-06 | -$8.00M derived: sum of 3 quarters · filed 2026-08-06 | $51.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $32.00M 10-Q · filed 2026-05-07 | $16.00M derived: sum of 2 quarters · filed 2026-05-07 | $75.00M derived: sum of 3 quarters · filed 2026-05-07 | $179.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $43.00M derived: sum of 2 quarters · filed 2026-02-12 | $147.00M derived: sum of 3 quarters · filed 2026-08-06 | $106.00M 10-K · filed 2026-02-12 | ||
| 2025-09-30 | $59.00M 10-Q · filed 2025-11-04 | $163.00M derived: sum of 2 quarters · filed 2026-08-06 | $122.00M 10-Q · filed 2025-11-04 | $162.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $104.00M 10-Q · filed 2026-08-06 | $140.00M 10-Q · filed 2025-08-05 | $192.00M 10-Q · filed 2026-08-06 | $63.00M 10-Q · filed 2025-08-05 | $103.00M derived: sum of 3 quarters · filed 2026-08-06 | $97.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $88.00M 10-Q · filed 2026-05-07 | -$77.00M 10-Q · filed 2025-05-06 | -$1.00M derived: sum of 2 quarters · filed 2026-05-07 | -$7.00M derived: sum of 3 quarters · filed 2026-05-07 | -$11.00M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$95.00M derived: sum of 2 quarters · filed 2026-02-12 | -$99.00M derived: sum of 3 quarters · filed 2026-02-12 | -$101.00M 10-K · filed 2026-02-12 | ||
| 2024-09-30 | -$6.00M 10-Q · filed 2025-11-04 | -$10.00M derived: sum of 2 quarters · filed 2025-11-04 | -$12.00M 10-Q · filed 2025-11-04 | -$37.00M derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-06-30 | -$4.00M 10-Q · filed 2025-08-05 | -$6.00M 10-Q · filed 2025-08-05 | -$31.00M derived: sum of 3 quarters · filed 2026-02-12 | $50.00M derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-03-31 | -$2.00M 10-Q · filed 2025-05-06 | -$27.00M derived: sum of 2 quarters · filed 2026-02-12 | $54.00M derived: sum of 3 quarters · filed 2026-02-12 | -$13.00M derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2023-12-31 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $56.00M derived: sum of 2 quarters · filed 2026-02-12 | -$11.00M derived: sum of 3 quarters · filed 2026-02-12 | -$22.00M 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $81.00M 10-Q · filed 2024-11-04 | $14.00M derived: sum of 2 quarters · filed 2024-11-04 | $3.00M 10-Q · filed 2024-11-04 | -$5.00M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-06-30 | -$67.00M 10-Q · filed 2024-08-06 | -$78.00M 10-Q · filed 2024-08-06 | -$86.00M derived: sum of 3 quarters · filed 2025-02-13 | -$173.00M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-03-31 | -$11.00M 10-Q · filed 2024-05-02 | -$19.00M derived: sum of 2 quarters · filed 2025-02-13 | -$106.00M derived: sum of 3 quarters · filed 2025-02-13 | -$124.00M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2022-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$95.00M derived: sum of 2 quarters · filed 2025-02-13 | -$113.00M derived: sum of 3 quarters · filed 2025-02-13 | -$53.00M 10-K · filed 2025-02-13 | ||
| 2022-09-30 | -$87.00M 10-Q · filed 2023-11-02 | -$105.00M derived: sum of 2 quarters · filed 2023-11-02 | -$45.00M 10-Q · filed 2023-11-02 | -$142.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | -$18.00M 10-Q · filed 2023-08-08 | $42.00M 10-Q · filed 2023-08-08 | -$55.00M derived: sum of 3 quarters · filed 2024-02-13 | -$99.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $60.00M 10-Q · filed 2023-05-04 | -$37.00M derived: sum of 2 quarters · filed 2024-02-13 | -$81.00M derived: sum of 3 quarters · filed 2024-02-13 | -$71.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | -$97.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$141.00M derived: sum of 2 quarters · filed 2024-02-13 | -$131.00M derived: sum of 3 quarters · filed 2024-02-13 | -$34.00M 10-K · filed 2024-02-13 | ||
| 2021-09-30 | -$44.00M 10-Q · filed 2022-11-03 | -$34.00M derived: sum of 2 quarters · filed 2022-11-03 | $63.00M 10-Q · filed 2022-11-03 | $68.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $10.00M 10-Q · filed 2022-08-04 | $107.00M 10-Q · filed 2022-08-04 | $112.00M derived: sum of 3 quarters · filed 2023-02-14 | $233.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $97.00M 10-Q · filed 2022-05-05 | $102.00M derived: sum of 2 quarters · filed 2023-02-14 | $223.00M derived: sum of 3 quarters · filed 2023-02-14 | $148.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $126.00M derived: sum of 2 quarters · filed 2023-02-14 | $51.00M derived: sum of 3 quarters · filed 2023-02-14 | -$4.00M 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $121.00M 10-Q · filed 2021-11-04 | $46.00M derived: sum of 2 quarters · filed 2021-11-04 | -$9.00M 10-Q · filed 2021-11-04 | -$36.00M derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2020-06-30 | -$75.00M 10-Q · filed 2021-08-05 | -$130.00M 10-Q · filed 2021-08-05 | -$157.00M derived: sum of 3 quarters · filed 2022-02-15 | -$187.00M derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2020-03-31 | -$55.00M 10-Q · filed 2021-05-06 | -$82.00M derived: sum of 2 quarters · filed 2022-02-15 | -$112.00M derived: sum of 3 quarters · filed 2022-02-15 | -$183.00M derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2019-12-31 | -$27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$57.00M derived: sum of 2 quarters · filed 2022-02-15 | -$128.00M derived: sum of 3 quarters · filed 2022-02-15 | -$97.00M 10-K · filed 2022-02-15 | ||
| 2019-09-30 | -$30.00M 10-Q · filed 2020-11-05 | -$101.00M derived: sum of 2 quarters · filed 2020-11-05 | -$70.00M 10-Q · filed 2020-11-05 | -$80.00M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-06-30 | -$71.00M 10-Q · filed 2020-08-06 | -$40.00M 10-Q · filed 2020-08-06 | -$50.00M derived: sum of 3 quarters · filed 2021-02-16 | -$126.00M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-03-31 | $31.00M 10-Q · filed 2020-05-06 | $21.00M derived: sum of 2 quarters · filed 2021-02-16 | -$55.00M derived: sum of 3 quarters · filed 2021-02-16 | -$170.00M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2018-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$86.00M derived: sum of 2 quarters · filed 2021-02-16 | -$201.00M derived: sum of 3 quarters · filed 2021-02-16 | -$124.00M 10-K · filed 2021-02-16 | ||
| 2018-09-30 | -$76.00M 10-Q · filed 2019-11-07 | -$191.00M derived: sum of 2 quarters · filed 2019-11-07 | -$114.00M 10-Q · filed 2019-11-07 | -$163.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | -$115.00M 10-Q · filed 2019-08-06 | -$38.00M 10-Q · filed 2019-08-06 | -$87.00M derived: sum of 3 quarters · filed 2020-02-13 | $1.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $77.00M 10-Q · filed 2019-05-02 | $28.00M derived: sum of 2 quarters · filed 2020-02-13 | $116.00M derived: sum of 3 quarters · filed 2020-02-13 | $126.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | -$49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $39.00M derived: sum of 2 quarters · filed 2020-02-13 | $49.00M derived: sum of 3 quarters · filed 2020-02-13 | $95.00M 10-K · filed 2020-02-13 | ||
| 2017-10-01 | $88.00M 10-Q · filed 2018-11-01 | $98.00M derived: sum of 2 quarters · filed 2018-11-01 | $144.00M 10-Q · filed 2018-11-01 | $51.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-07-02 | $10.00M 10-Q · filed 2018-08-02 | $56.00M 10-Q · filed 2018-08-02 | -$37.00M derived: sum of 3 quarters · filed 2019-02-14 | $12.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-04-02 | $46.00M 10-Q · filed 2018-05-02 | -$47.00M derived: sum of 2 quarters · filed 2019-02-14 | $2.00M derived: sum of 3 quarters · filed 2019-02-14 | $64.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2016-12-31 | -$93.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$44.00M derived: sum of 2 quarters · filed 2019-02-14 | $18.00M derived: sum of 3 quarters · filed 2019-02-14 | $21.00M 10-K · filed 2019-02-14 | ||
| 2016-10-02 | $49.00M 10-Q · filed 2017-11-02 | $111.00M derived: sum of 2 quarters · filed 2017-11-02 | $114.00M 10-Q · filed 2017-11-02 | $54.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-07-03 | $62.00M 10-Q · filed 2017-08-08 | $65.00M 10-Q · filed 2017-08-08 | $5.00M derived: sum of 3 quarters · filed 2018-02-15 | -$55.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-04-03 | $3.00M 10-Q · filed 2017-05-04 | -$57.00M derived: sum of 2 quarters · filed 2018-02-15 | -$117.00M derived: sum of 3 quarters · filed 2018-02-15 | -$142.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | -$60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$120.00M derived: sum of 2 quarters · filed 2018-02-15 | -$145.00M derived: sum of 3 quarters · filed 2018-02-15 | -$262.00M 10-K · filed 2018-02-15 | ||
| 2015-09-27 | -$60.00M 10-Q · filed 2016-11-03 | -$85.00M derived: sum of 2 quarters · filed 2016-11-03 | -$202.00M 10-Q · filed 2016-11-03 | -$314.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-06-28 | -$25.00M 10-Q · filed 2016-08-05 | -$142.00M 10-Q · filed 2016-08-05 | -$254.00M derived: sum of 3 quarters · filed 2017-02-16 | -$293.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-03-29 | -$117.00M 10-Q · filed 2016-05-06 | -$229.00M derived: sum of 2 quarters · filed 2017-02-16 | -$268.00M derived: sum of 3 quarters · filed 2017-02-16 | -$239.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2014-12-31 | -$112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$151.00M derived: sum of 2 quarters · filed 2017-02-16 | -$122.00M derived: sum of 3 quarters · filed 2017-02-16 | -$130.00M 10-K · filed 2017-02-16 | ||
| 2014-09-28 | -$39.00M 10-Q · filed 2015-11-05 | -$10.00M derived: sum of 2 quarters · filed 2015-11-05 | -$18.00M 10-Q · filed 2015-11-05 | $8.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $29.00M 10-Q · filed 2015-08-06 | $21.00M 10-Q · filed 2015-08-06 | $47.00M derived: sum of 3 quarters · filed 2016-02-24 | -$15.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | -$8.00M 10-Q · filed 2015-05-07 | $18.00M derived: sum of 2 quarters · filed 2016-02-24 | -$44.00M derived: sum of 3 quarters · filed 2016-02-24 | -$78.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$36.00M derived: sum of 2 quarters · filed 2016-02-24 | -$70.00M derived: sum of 3 quarters · filed 2016-02-24 | -$56.00M 10-K · filed 2016-02-24 | ||
| 2013-09-29 | -$62.00M 10-Q · filed 2014-11-10 | -$96.00M derived: sum of 2 quarters · filed 2014-11-10 | -$82.00M 10-Q · filed 2014-11-10 | -$70.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | -$34.00M 10-Q · filed 2014-08-12 | -$20.00M 10-Q · filed 2014-08-12 | -$8.00M derived: sum of 3 quarters · filed 2015-02-27 | $16.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $14.00M 10-Q · filed 2014-05-13 | $26.00M derived: sum of 2 quarters · filed 2015-02-27 | $50.00M derived: sum of 3 quarters · filed 2015-02-27 | -$112.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $36.00M derived: sum of 2 quarters · filed 2015-02-27 | -$126.00M derived: sum of 3 quarters · filed 2015-02-27 | -$92.00M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $24.00M 10-Q · filed 2013-11-13 | -$138.00M derived: sum of 2 quarters · filed 2013-11-13 | -$104.00M 10-Q · filed 2013-11-13 | |||
| 2012-07-01 | -$162.00M 10-Q · filed 2013-08-14 | -$128.00M 10-Q · filed 2013-08-14 | ||||
| 2012-04-01 | $34.00M 10-Q · filed 2013-05-15 | |||||
| 2011-12-31 | $9.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |